Quality of Life Research

, Volume 1, Issue 3, pp 203–210

Report from a National Cancer Institute (USA) workshop on quality of life assessment in cancer clinical trials

  • S. G. Nayfield
  • P. A. Ganz
  • C. M. Moinpour
  • D. F. Cella
  • B. J. Hailey
Special Report

DOI: 10.1007/BF00635619

Cite this article as:
Nayfield, S.G., Ganz, P.A., Moinpour, C.M. et al. Qual Life Res (1992) 1: 203. doi:10.1007/BF00635619

Abstract

To promote the inclusion of quality of life (QOL) end-points in clinical research on cancer, the National Cancer Institute (USA) sponsored a workshop on QOL assessment in cancer clinical trials in July, 1990. Experts in clinical trials and QOL research formed four working groups to identify current areas of cancer treatment in which QOL end-points are most important; to discuss methodologic problems in QOL assessment; to address common problems in implementing clinical studies with QOL end-points; and to consider statistical issues in design, implementation, and data analysis. Recommendations made by the working groups are summarized in this paper.

Key words

Assessment methodscancerclinical trialsquality of life

Copyright information

© Rapid Communications of Oxford Ltd 1992

Authors and Affiliations

  • S. G. Nayfield
    • 1
  • P. A. Ganz
    • 2
  • C. M. Moinpour
    • 3
  • D. F. Cella
    • 4
  • B. J. Hailey
    • 5
  1. 1.Community Oncology and Rehabilitation Branch, Division of Cancer Prevention and ControlNational Cancer InstituteBethesdaUSA
  2. 2.UCLA-San Fernando Valley ProgramVeterans Affairs Medical CenterSepulvedaUSA
  3. 3.Fred Hutchinson Cancer Research CenterSeattleUSA
  4. 4.Rush-Presbyterian-St Luke's Medical CenterChicagoUSA
  5. 5.University of Southern MississippiHattiesburgUSA